Complications Associated With Lymphadenectomy (LAD) in Surgical Treatment of Non-small Cell Lung Cancer (NSCLC).

Systemic mediastinal lymph node dissection is a standard step in radical surgery for advanced non-small cell lung cancer (NSCLC). However, it does not carry the risks associated with certain procedures (chylothorax, recurrent nerve palsy, diaphragmatic relaxation, intrapleural hemorrhage, injury to other chest organs (esophagus, great vessels), etc.). Data on their incidence and predictors in routine practice are limited. Objective: To assess trends and characteristics of projects directly related to Lymph Node Dissection and to identify independent risk factors for their development.

NCT Number	NCT07401498
Lead Sponsor	Regional Clinical Oncology Dispensary Collaborators: National Medical Research Center of Phthisiopulmonology and Infectious Diseases, National Medical Research Radiological Centre of the Ministry of Health of Russia
Conditions	Lymph Node Dissection, Advanced Non-small Cell Lung Cancer (NSCLC)
Enrollment	1,000 participants
Start Date	2025-08-14
Primary Completion	2026-08 (estimated)
Study Completion	2026-08 (estimated)
Updated on ClinicalTrials.gov	2026-02-10